Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Global X NASDAQ 100 Covered Call ETF (QYLD) vs Sanofi SA (SNY) Price & Performance

Global X NASDAQ 100 Covered Call ETFTrade

Price performance (Past 24H)

Key statistics

Global X NASDAQ 100 Covered Call ETF vs Sanofi SA — how do they compare? Global X NASDAQ 100 Covered Call ETF trades at $17.87, while Sanofi SA trades at $43.89 (market cap $104.85B). The key difference: Sanofi SA pays a 5.53% dividend while Global X NASDAQ 100 Covered Call ETF pays none, and Global X NASDAQ 100 Covered Call ETF is trading nearer its 52-week high, Sanofi SA nearer its low. Which is the better fit depends on your goals.

QYLDSNY
Sector
Income / Options OverlayHealth
52-Week High
$18.52$52.34
52-Week Low
$16.46$41.33
Market Cap
$104.85B
Enterprise Value
$121.38B
Dividend Yield
5.53%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Global X NASDAQ 100 Covered Call ETF

QYLD is an ETF that follows a covered call strategy on the NASDAQ 100 Index. The fund holds a long position in the stocks of the NASDAQ 100 and simultaneously writes (sells) call options on the index. The primary goal is to generate monthly income from the option premiums. This strategy can reduce portfolio volatility and provide income, but it limits potential capital appreciation from a significant rise in the NASDAQ 100 Index.

Read more on QYLD

About Sanofi SA

Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

Read more on SNY